Edition:
United States

Calithera Biosciences Inc (CALA.OQ)

CALA.OQ on NASDAQ Stock Exchange Global Select Market

4.75USD
4:00pm EDT
Change (% chg)

$-0.05 (-1.04%)
Prev Close
$4.80
Open
$4.85
Day's High
$4.93
Day's Low
$4.70
Volume
31,479
Avg. Vol
52,743
52-wk High
$18.30
52-wk Low
$4.07

Select another date:

Thu, May 10 2018

BRIEF-Calithera Biosciences Q1 Loss Per Share $0.37

* CALITHERA BIOSCIENCES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

BRIEF-Calithera Biosciences Announces FDA Fast Track Designation Granted To CB-839 In Combination With Cabozantinib For Treatment Of Patients With Advanced Renal Cell Carcinoma

* CALITHERA BIOSCIENCES ANNOUNCES FDA FAST TRACK DESIGNATION GRANTED TO CB-839 IN COMBINATION WITH CABOZANTINIB FOR TREATMENT OF PATIENTS WITH ADVANCED RENAL CELL CARCINOMA Source text for Eikon: Further company coverage:

Select another date: